INTERSTITIAL LUNG DISEASE

✓ Medically ReviewedDISEASEID: MDBT0066🚨 TRIAGE: ROUTINEICD-10: J84.9

📖

Definition

CLINICAL DEFINITION

Interstitial lung disease is a group of diffuse parenchymal disorders (conditions of sacs and supporting tissue). It involves inflammation and fibrosis (scarring) of the interstitium (lace-like network around sacs). It causes progressive breathlessness, dry cough and restrictive physiology (stiff lungs with small volumes and poor gas transfer). Diagnosis needs clinical review, high-resolution CT pattern reading and often multidisciplinary discussion (joint expert review).

IN PLAIN ENGLISH

The thin walls around tiny air sacs become swollen or scarred. Scarred lungs turn stiff and pass less oxygen to blood. This causes breathlessness with effort and a dry cough. It often builds slowly and needs specialist lung care.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Interstitial lung disease is not asthma or COPD (airway narrowing with wheeze and reversible limitation). It is not bacterial pneumonia (acute infection with fever and phlegm) that clears with antibiotics. It is not pulmonary oedema (heart failure fluid) that lifts fast with diuretics (fluid removers). It is not lung cancer (focal mass growth) despite shared cough and breathlessness.

🔤

Word Breakdown

inter-

=between

stit-

=to stand or support

-ial

=pertaining to

Literal Meaning: pertaining to spaces between supporting lung tissue

🏷️

Abbreviations

ILD=Interstitial lung disease - diffuse scarring of lung framework

IPF=Idiopathic pulmonary fibrosis - scarring of unknown cause with UIP pattern

NSIP=Nonspecific interstitial pneumonia - uniform inflammation and fibrosis pattern

HP=Hypersensitivity pneumonitis - lung allergy to inhaled dusts or antigens

UIP=Usual interstitial pneumonia - basal honeycomb scarring pattern

HRCT=High-resolution CT - detailed lung scan showing scarring pattern

DLCO=Diffusing capacity for carbon monoxide - gas transfer test

🔄

Synonyms & Variants

Diffuse parenchymal lung disease›Interstitial pneumonia›Diffuse interstitial lung disorder›

🎯

Category-Specific Context

Interstitial lung disease is a Disease because it is a family of related conditions with causes and course. It groups over two hundred entities (distinct diagnoses) by diffuse framework involvement. It differs from a Symptom (patient complaint) such as breathlessness and a Sign (exam finding) such as crackles. Workup targets cause, fibrosis stage and disease-modifying therapy.

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Respiratory ClinicInterstitial Lung Disease Multidisciplinary MeetingRheumatology ClinicOccupational Lung ClinicEmergency Department for Acute Exacerbation

USAGE & DOCUMENTATION NOTES

Use interstitial lung disease when imaging shows reticular (net-like), ground-glass (hazy) or honeycomb change with restriction. Specify suspected subtype such as idiopathic fibrosis or hypersensitivity pneumonitis when possible. Record exposures, drugs, autoimmunity clues and family history. Do not label acute heart fluid or focal pneumonia as interstitial disease.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

Repeat sac lining injury activates innate and adaptive immunity (early and targeted defence). Profibrotic signals such as transforming growth factor beta drive fibroblast growth and scar cell change. Excess collagen thickens sac walls and closes airspaces, cutting stretch and gas transfer. Traction dilation (pulled airways) and honeycombing (clustered cyst remodelling) mark advanced distortion. Low oxygen and lung hypertension (high lung pressure) follow air-blood mismatch.

PRIMARY CAUSES

Idiopathic pulmonary fibrosis with UIP pattern

Repeat tiny lining injury triggers faulty healing with fibroblast activation and collagen scarring

Nonspecific interstitial pneumonia often with connective tissue disease

Uniform wall inflammation and fibrosis cause symmetric haze and restriction without honeycombing

Hypersensitivity pneumonitis from moulds, birds or chemicals

Immune sensitisation drives white cell inflammation of sacs that fibroses with ongoing exposure

Connective tissue disease such as rheumatoid arthritis and systemic sclerosis

Systemic autoimmunity targets interstitium and vessels with joint, skin or muscle disease

Sarcoidosis with granulomatous lung disease

Organised immune nodules infiltrate lymphatics and interstitium with upper lobe fibrosis

Pneumoconiosis from silica, asbestos or coal dust

Retained mineral dust provokes macrophage activation and scar signals with nodular fibrosis

Radiation-induced and unclassifiable fibrotic injury

Ionising injury damages lining and vessels with organising inflammation and progressive scarring

💊

Drug-Induced Causes

💊 Amiodarone ↗

Mechanism: Phospholipid and cytotoxic injury causes diffuse infiltrates and organising pneumonia

→ Stop drug with cardiology input, give oxygen support and consider steroids for severe disease with long monitoring

💊 Nitrofurantoin ↗

Mechanism: Oxidative and allergy injury causes acute inflammation or chronic fibrosis with prolonged use

→ Stop drug for good, assess for lasting fibrosis, use steroids for severe allergy and never rechallenge

💊 Bleomycin ↗

Mechanism: Free radical injury impairs DNA repair causing dose-related pneumonitis to fibrosis

→ Withhold drug with oncology input, give supportive care and steroids for pneumonitis with lung function watch

💊 Methotrexate ↗

Mechanism: Allergy-type pneumonitis triggers white cell inflammation with fever and haze rather than dose effect

→ Stop drug with rheumatology input, exclude infection, use steroids for severe disease and switch therapy

🌍

Epidemiology

Prevalence:Interstitial lung disease is uncommon in general practice but regular in respiratory clinics. Idiopathic fibrosis (unknown-cause scarring) rises sharply with age. Connective tissue related disease tracks autoimmunity burden. Occupational and allergy types cluster with farming, mould, bird, silica and asbestos exposure.

Age Group:Most fibrotic disease presents in middle to older adulthood with effort symptoms. Idiopathic fibrosis typically affects older adults. Younger adults more often have sarcoidosis, connective tissue disease or hypersensitivity pneumonitis. Children are rarely affected and need genetic review.

Geographic Distribution:Interstitial lung disease occurs worldwide with pattern shifts by exposures and detection. Dust fibrosis concentrates in mining, quarrying, sandblasting and construction regions. Allergy pneumonitis follows farming, mouldy hay, hot tubs and bird keeping. Scan and team access shape recorded frequency.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 ROUTINE

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Acute exacerbation with new haze on fibrosis needing urgent oxygen and workup
Connective tissue disease with subtle joint, skin or muscle clues needing antibody tests
Hypersensitivity pneumonitis with ongoing mould or bird exposure needing removal
Drug injury needing prompt withdrawal of amiodarone, nitrofurantoin, bleomycin or methotrexate
Lung hypertension and cancer arising in chronic fibrosis

URGENT EVALUATION TRIGGERS

Worse breathlessness at rest with low oxygen or blue lips
Fever with new shadows suggesting infection or acute flare-up
Chest pain with fast heart suggesting clot or collapsed lung
Coughing blood or weight loss suggesting cancer or severe infection
Drug toxicity with liver or gut upset on antifibrotic or immune therapy

Contraindications & Precautions

CONTRAINDICATIONS

Do not continue fibrogenic drug when injury is suspected without specialist review
Do not give high-dose immune suppression alone for confirmed idiopathic fibrosis without expert guidance
Do not delay oxygen review and transplant referral in eligible progressive fibrosis

SPECIAL PRECAUTIONS

Monitor blood counts, liver and lung function on immune or antifibrotic therapy
Update influenza, pneumococcal, COVID and RSV vaccines where eligible
Advise smoking stop, dust avoidance and rehab with oxygen planning
Screen for reflux, sleep apnoea and mood change that worsen breathlessness

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Progressive breathlessness to resting low oxygen
Pulmonary hypertension with right heart strain
Acute exacerbation with rapid respiratory failure
Recurrent infection from distorted airways and immune drugs
Lung cancer in fibrotic areas with drug adverse effects

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Interstitial cystitis

Shares interstitial prefix but is bladder pain with urgency, not lung scarring

Intestinal disease

Misheard as intestinal but intestinal is bowel inflammation, not sac framework disease

Obstructive lung disease

Both cause breathlessness but obstructive disease shows wheeze with airflow limitation while interstitial shows restriction with low transfer

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

COPD

Key Distinguishing Feature: Obstructive blow test with hyperinflation and smoking history versus restriction with low transfer and Velcro crackles

Acute left heart failure with oedema

Key Distinguishing Feature: Flat breathlessness with bat-wing oedema and high peptides easing with diuretics versus lasting reticular fibrosis

Community-acquired pneumonia

Key Distinguishing Feature: Fever with focal consolidation clearing with antibiotics versus chronic dry cough with reticular scan change

Pulmonary embolism

Key Distinguishing Feature: Abrupt pleuritic pain with clot on angiography versus slow effort breathlessness with interstitial pattern

Bronchiectasis

Key Distinguishing Feature: Wet purulent cough with tram-track airways versus dry cough with basal honeycombing and traction from fibrosis

💎

Clinical Pearls

💎

Listen for fine late Velcro crackles at the bases with finger clubbing as a fibrosis clue. Early disease needs HRCT (detailed scan) not X-ray alone.

💎

Ask birds, moulds, hot tubs, drugs, dusts, family fibrosis and autoimmunity before labelling idiopathic. Removal of exposure can halt allergy disease.

💎

Track forced vital capacity and DLCO (gas transfer) trends with walk oximetry over time. Trends beat single values for progression calls.

💎

Discuss antifibrotics pirfenidone and nintedanib early for progressive fibrosis with transplant referral without delay. Eligibility windows close fast.

💎

Vaccinate, rehabilitate and assess oxygen needs while screening for lung hypertension, reflux and sleep apnoea. These co-traits drive breathlessness.

📝

Example Usage & SOAP

CLINICAL SENTENCE

""68-year-old man with effort breathlessness and basal Velcro crackles has interstitial lung disease.""

IN A SOAP NOTE

S: 68-year-old man reports 8 months worse breathlessness climbing stairs and dry cough without wheeze or sputum. O: Temp 36.8C, BP 132/78, HR 84, RR 20, SpO2 93 percent rest and 88 percent after walking, fine late crackles both bases, early clubbing. A: Suspected interstitial lung disease with UIP pattern and moderate restriction. P: High-resolution CT, full lung function with DLCO, walk oximetry, autoimmune panel, exposure review, multidisciplinary discussion, vaccine and smoking counsel.

DIFFERENTIAL DIAGNOSIS CONTEXT

Chronic dry cough with effort breathlessness suggests interstitial disease when Velcro crackles and restriction with low transfer fit. Obstructive blow test with wheeze favours COPD (airway disease). Bat-wing fluid easing with diuretics favours heart failure. Basal honeycombing (clustered cysts) on HRCT favours fibrosis.

📊

Classifications & Scoring

GRADING SYSTEM

ATS ERS Classification of Idiopathic Interstitial Pneumonias

Consensus framework grouping idiopathic patterns by clinical, imaging and pathology features to guide diagnosis and care

SCORING TOOL

GAP Model

Gender age physiology model using sex, age and lung function to estimate death risk in idiopathic fibrosis for counsel and referral

📈

Prognosis

SHORT-TERM OUTCOME

Short term course varies by subtype and gas transfer loss. Stable nonspecific disease may hold for months with treatment. Acute flare-up (sudden worsening) can cause rapid low oxygen and admission. Early oxygen review, infection exclusion and escalation planning improve safety.

LONG-TERM PROGNOSIS

Course spans reversible allergy disease to relentless progressive fibrosis. Idiopathic fibrosis often progresses despite therapy and shortens survival. Connective tissue and inflammatory subtypes may stabilise with immune calming treatment. All progressive fibrosis needs rehab, vaccines and transplant review where eligible.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

J84.9

LITERATURE CITATIONS & GUIDELINES

[1]Travis et al ATS ERS classification of idiopathic interstitial pneumonias

[2]Raghu et al Guideline on idiopathic pulmonary fibrosis

[3]Harrison's Principles of Internal Medicine

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.